305
Views
21
CrossRef citations to date
0
Altmetric
Drug Evaluations

Galiximab: a review

, MD & , MD
Pages 451-458 | Published online: 22 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jack W Hsu & Nam H Dang. (2013) The role of monoclonal antibodies in the treatment of lymphomas. Expert Opinion on Biological Therapy 13:2, pages 227-239.
Read now

Articles from other publishers (20)

Hirotaka Miyashita, Razelle Kurzrock, Nicholas J. Bevins, Kartheeswaran Thangathurai, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Sean T. Glenn, Jeffrey M. Conroy, Paul DePietro, Eitan Rubin, Jason K. Sicklick & Shumei Kato. (2023) T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy. npj Genomic Medicine 8:1.
Crossref
Yoong Mond Teh, Soo Kun Lim, Norhana Jusoh, Kahar Osman & Siti Aisyah Mualif. (2021) CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease. BioMed Research International 2021, pages 1-17.
Crossref
Rui Chen, Aravindhan Ganesan, Isobel Okoye, Elena Arutyunova, Shokrollah Elahi, M. Joanne Lemieux & Khaled Barakat. (2020) Targeting B7‐1 in immunotherapy. Medicinal Research Reviews 40:2, pages 654-682.
Crossref
Carlos Cuesta-Mateos, Ana Alcaraz-Serna, Beatriz Somovilla-Crespo & Cecilia Muñoz-Calleja. (2018) Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets. Frontiers in Immunology 8.
Crossref
Tae-Hyun Yoo & Alessia Fornoni. (2015) Nonimmunologic targets of immunosuppressive agents in podocytes. Kidney Research and Clinical Practice 34:2, pages 69-75.
Crossref
Manzoor Ahmad Mir. 2015. Developing Costimulatory Molecules for Immunotherapy of Diseases. Developing Costimulatory Molecules for Immunotherapy of Diseases 185 254 .
Maryam Ebadi, Nishitha M. Reddy & Nima Rezaei. 2015. Cancer Immunology. Cancer Immunology 135 183 .
Monika Podhorecka, Justyna Markowicz, Agnieszka Szymczyk & Johannes Pawlowski. (2014) Target Therapy in Hematological Malignances: New Monoclonal Antibodies. International Scholarly Research Notices 2014, pages 1-16.
Crossref
Joseph R. Podojil & Stephen D. Miller. (2012) Targeting the B7 Family of Co-Stimulatory Molecules. BioDrugs 27:1, pages 1-13.
Crossref
Tadeusz Robak. (2013) Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia. Future Oncology 9:1, pages 69-91.
Crossref
Tadeusz Robak. 2013. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 191 212 .
Guilherme F. Perini & Luis E. Fayad. 2013. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 173 189 .
M.S. Czuczman, J.P. Leonard, S. Jung, J.L. Johnson, E.D. Hsi, J.C. Byrd & B.D. Cheson. (2012) Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness. Annals of Oncology 23:9, pages 2356-2362.
Crossref
Felix Braun, Thomas Becker, Lutz Renders & Burckhardt Ringe. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Alan S. Wayne. 2013. Childhood Leukemias. Childhood Leukemias 563 581 .
Tadeusz Robak. (2012) Przeciwciała monoklonalne w leczeniu przewlekłej białaczki limfocytowej. Acta Haematologica Polonica 43:2, pages 99-106.
Crossref
Katja Van HerleJacinta M. Behne, Andre Van HerleTerrence F. Blaschke, Terry J. Smith & Michael R. Yeaman. (2012) Integrative Continuum: Accelerating Therapeutic Advances in Rare Autoimmune Diseases. Annual Review of Pharmacology and Toxicology 52:1, pages 523-547.
Crossref
Tom van Meerten & Anton Hagenbeek. (2011) Novel antibodies against follicular non-Hodgkin’s lymphoma. Best Practice & Research Clinical Haematology 24:2, pages 231-256.
Crossref
Henk-Jan Schuurman. 2011. Principles of Immunopharmacology. Principles of Immunopharmacology 525 556 .
Quazi Shakey, Brian Bates & Jiang Wu. (2010) An Approach to Quantifying N-Linked Glycoproteins by Enzyme-Catalyzed 18 O 3 -Labeling of Solid-Phase Enriched Glycopeptides . Analytical Chemistry 82:18, pages 7722-7728.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.